Evidence map›Paper›PMID 34539984›Full record

ArticleAmerican journal of translational research2021

The regulatory relationship and function of LncRNA FAM225A-miR-206-ADAM12 in gastric cancer.

Nan Chen, Xuedan Zhu, Yinxing Zhu, Junfeng Shi, Juan Zhang, Cuiju Tang, Jinfei Chen

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. LncRNA and its role in gastric cancer immunotherapy.Frontiers in cell and developmental biology · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nan ChenDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China.
Xuedan ZhuDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China.
Yinxing ZhuDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China.
Junfeng ShiDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China.
Juan ZhangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China.
Cuiju TangDepartment of Oncology, Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China.
Jinfei ChenCancer Center, Taikang Xianlin Drum Tower Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the role and functions of FAM225A in gastric cancer.

methodsThe expressions of FAM225A, miR-206, ADAM12 and epithelial-mesenchymal transition (EMT)-related genes were detected by quantitative real-time PCR and Western blot. Functional experiments including cell counting kit-8, colony formation, wound-healing, and Transwell assays were conducted to analyze the biological characteristics of gastric cancer cells in different groups. Bioinformatics, dual-luciferase reporter assay and Pearson correlation coefficients were performed for determining the regulatory relationship of lncRNA-miRNA-mRNA.

resultsIn gastric cancer, FAM225A and ADAM12 expressions were up-regulated, while miR-206 expression was down-regulated. Opposite to the regulatory effects of overexpressed FAM225A, blocking FAM225A expression reduced cell viability, migration, invasion and number of cell clones, increased E-Cadherin expression, inhibited N-Cadherin and Vimentin expressions, and ultimately promoted tumor growth. MiR-206 inhibitor partially offset the effects of siFAM225A. Moreover, FAM225A competitively bound to miR-206 to up-regulate ADAM12 expression. Overexpressed ADAM12 partially reversed the effect of miR-206 mimic on the biological characteristics of gastric cancer cells and EMT-related proteins.

conclusionOur research revealed that FAM225A-miR-206-ADAM12 axis may be a potential pathway for regulating gastric cancer.

Indexed as

ADAM12Gastric cancerlncRNA FAM225AmiR-206proliferation

Identifiers

PMID34539984
PMCPMC8430187
OpenAlexW3200777539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.